
The global Bioresorbable Medical Material market size is predicted to grow from US$ 1783 million in 2025 to US$ 3099 million in 2031; it is expected to grow at a CAGR of 9.6% from 2025 to 2031.
The bioresorbable medical material in this report contains polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL) and PLGA.
Global Bioresorbable Medical Material key players include Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, etc. Global top five manufacturers hold a share over 50%.
USA is the largest market, with a share over 40%, followed by Europe and China, both have a share over 35% percent. In terms of product, PLA is the largest segment, with a share over 20%. And in terms of application, the largest application is Orthopedics, followed by Drug Delivery.
The “Bioresorbable Medical Material Industry Forecast” looks at past sales and reviews total world Bioresorbable Medical Material sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioresorbable Medical Material sales for 2025 through 2031. With Bioresorbable Medical Material sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioresorbable Medical Material industry.
This Insight Report provides a comprehensive analysis of the global Bioresorbable Medical Material landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioresorbable Medical Material portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioresorbable Medical Material market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioresorbable Medical Material and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioresorbable Medical Material.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioresorbable Medical Material market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polysaccharides
Polycaprolactone (PCL)
PLGA
Segmentation by Application:
Drug Delivery
Orthopedics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Evonik
Corbion
DSM
Mitsui Chemicals
PCAS
Poly-Med
KLS Martin
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bioresorbable Medical Material market?
What factors are driving Bioresorbable Medical Material market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bioresorbable Medical Material market opportunities vary by end market size?
How does Bioresorbable Medical Material break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bioresorbable Medical Material Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bioresorbable Medical Material by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bioresorbable Medical Material by Country/Region, 2020, 2024 & 2031
2.2 Bioresorbable Medical Material Segment by Type
2.2.1 Polylactic Acid (PLA)
2.2.2 Polyglycolic Acid (PGA)
2.2.3 Polysaccharides
2.2.4 Polycaprolactone (PCL)
2.2.5 PLGA
2.3 Bioresorbable Medical Material Sales by Type
2.3.1 Global Bioresorbable Medical Material Sales Market Share by Type (2020-2025)
2.3.2 Global Bioresorbable Medical Material Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bioresorbable Medical Material Sale Price by Type (2020-2025)
2.4 Bioresorbable Medical Material Segment by Application
2.4.1 Drug Delivery
2.4.2 Orthopedics
2.4.3 Others
2.5 Bioresorbable Medical Material Sales by Application
2.5.1 Global Bioresorbable Medical Material Sale Market Share by Application (2020-2025)
2.5.2 Global Bioresorbable Medical Material Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bioresorbable Medical Material Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Bioresorbable Medical Material Breakdown Data by Company
3.1.1 Global Bioresorbable Medical Material Annual Sales by Company (2020-2025)
3.1.2 Global Bioresorbable Medical Material Sales Market Share by Company (2020-2025)
3.2 Global Bioresorbable Medical Material Annual Revenue by Company (2020-2025)
3.2.1 Global Bioresorbable Medical Material Revenue by Company (2020-2025)
3.2.2 Global Bioresorbable Medical Material Revenue Market Share by Company (2020-2025)
3.3 Global Bioresorbable Medical Material Sale Price by Company
3.4 Key Manufacturers Bioresorbable Medical Material Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bioresorbable Medical Material Product Location Distribution
3.4.2 Players Bioresorbable Medical Material Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Bioresorbable Medical Material by Geographic Region
4.1 World Historic Bioresorbable Medical Material Market Size by Geographic Region (2020-2025)
4.1.1 Global Bioresorbable Medical Material Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bioresorbable Medical Material Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bioresorbable Medical Material Market Size by Country/Region (2020-2025)
4.2.1 Global Bioresorbable Medical Material Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bioresorbable Medical Material Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bioresorbable Medical Material Sales Growth
4.4 APAC Bioresorbable Medical Material Sales Growth
4.5 Europe Bioresorbable Medical Material Sales Growth
4.6 Middle East & Africa Bioresorbable Medical Material Sales Growth
5 Americas
5.1 Americas Bioresorbable Medical Material Sales by Country
5.1.1 Americas Bioresorbable Medical Material Sales by Country (2020-2025)
5.1.2 Americas Bioresorbable Medical Material Revenue by Country (2020-2025)
5.2 Americas Bioresorbable Medical Material Sales by Type (2020-2025)
5.3 Americas Bioresorbable Medical Material Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bioresorbable Medical Material Sales by Region
6.1.1 APAC Bioresorbable Medical Material Sales by Region (2020-2025)
6.1.2 APAC Bioresorbable Medical Material Revenue by Region (2020-2025)
6.2 APAC Bioresorbable Medical Material Sales by Type (2020-2025)
6.3 APAC Bioresorbable Medical Material Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bioresorbable Medical Material by Country
7.1.1 Europe Bioresorbable Medical Material Sales by Country (2020-2025)
7.1.2 Europe Bioresorbable Medical Material Revenue by Country (2020-2025)
7.2 Europe Bioresorbable Medical Material Sales by Type (2020-2025)
7.3 Europe Bioresorbable Medical Material Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bioresorbable Medical Material by Country
8.1.1 Middle East & Africa Bioresorbable Medical Material Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bioresorbable Medical Material Revenue by Country (2020-2025)
8.2 Middle East & Africa Bioresorbable Medical Material Sales by Type (2020-2025)
8.3 Middle East & Africa Bioresorbable Medical Material Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bioresorbable Medical Material
10.3 Manufacturing Process Analysis of Bioresorbable Medical Material
10.4 Industry Chain Structure of Bioresorbable Medical Material
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bioresorbable Medical Material Distributors
11.3 Bioresorbable Medical Material Customer
12 World Forecast Review for Bioresorbable Medical Material by Geographic Region
12.1 Global Bioresorbable Medical Material Market Size Forecast by Region
12.1.1 Global Bioresorbable Medical Material Forecast by Region (2026-2031)
12.1.2 Global Bioresorbable Medical Material Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bioresorbable Medical Material Forecast by Type (2026-2031)
12.7 Global Bioresorbable Medical Material Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Evonik
13.1.1 Evonik Company Information
13.1.2 Evonik Bioresorbable Medical Material Product Portfolios and Specifications
13.1.3 Evonik Bioresorbable Medical Material Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Evonik Main Business Overview
13.1.5 Evonik Latest Developments
13.2 Corbion
13.2.1 Corbion Company Information
13.2.2 Corbion Bioresorbable Medical Material Product Portfolios and Specifications
13.2.3 Corbion Bioresorbable Medical Material Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Corbion Main Business Overview
13.2.5 Corbion Latest Developments
13.3 DSM
13.3.1 DSM Company Information
13.3.2 DSM Bioresorbable Medical Material Product Portfolios and Specifications
13.3.3 DSM Bioresorbable Medical Material Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 DSM Main Business Overview
13.3.5 DSM Latest Developments
13.4 Mitsui Chemicals
13.4.1 Mitsui Chemicals Company Information
13.4.2 Mitsui Chemicals Bioresorbable Medical Material Product Portfolios and Specifications
13.4.3 Mitsui Chemicals Bioresorbable Medical Material Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Mitsui Chemicals Main Business Overview
13.4.5 Mitsui Chemicals Latest Developments
13.5 PCAS
13.5.1 PCAS Company Information
13.5.2 PCAS Bioresorbable Medical Material Product Portfolios and Specifications
13.5.3 PCAS Bioresorbable Medical Material Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 PCAS Main Business Overview
13.5.5 PCAS Latest Developments
13.6 Poly-Med
13.6.1 Poly-Med Company Information
13.6.2 Poly-Med Bioresorbable Medical Material Product Portfolios and Specifications
13.6.3 Poly-Med Bioresorbable Medical Material Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Poly-Med Main Business Overview
13.6.5 Poly-Med Latest Developments
13.7 KLS Martin
13.7.1 KLS Martin Company Information
13.7.2 KLS Martin Bioresorbable Medical Material Product Portfolios and Specifications
13.7.3 KLS Martin Bioresorbable Medical Material Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 KLS Martin Main Business Overview
13.7.5 KLS Martin Latest Developments
14 Research Findings and Conclusion
*If Applicable.
